ANTHONY GRAVES: Open Payments
NPI 1417341330 · PASO ROBLES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 11 payments from 7 companies in 2025. Trend: 2023 $33 · 2024 $34 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $69 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Almatica Pharma LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, Tlando, Rybelsus, GARDASIL 9, PREVNAR 20, LOREEV XR, JARDIANCE.
Industry payments across CA — which companies pay providers there.
